Location: Palo Alto, CA
CIK: 0001839948 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $4.161B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZLAB | ZAI LAB LTD-ADR | 6,137,627 | $117M | 2.8% | — | — | ADRS | 98887Q104 |
| AURA | AURA BIOSCIENCES INC | 9,533,333 | $67.69M | 1.6% | — | — | COMM | 05153U107 |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS | 2,895,304 | $58.25M | 1.4% | — | — | COMM | 337185102 |
| EDIT | EDITAS MEDICINE INC | 11,111,111 | $36M | 0.9% | — | — | COMM | 28106W103 |
| PHVS | PHARVARIS BV | 1,008,229 | $34.86M | 0.8% | — | — | COMM | N69605108 |
| IFRX | INFLARX N V | 14,500,000 | $32.48M | 0.8% | — | — | COMM | N44821101 |
| ALT | ALTIMMUNE INC | 10,000,000 | $30.4M | 0.7% | — | — | COMM | 02155H200 |
| AKTS | AKTIS ONCOLOGY INC | 696,560 | $22.45M | 0.5% | — | — | COMM | 01021M104 |
| FBRX | FORTE BIOSCIENCES INC | 920,000 | $19.55M | 0.5% | — | — | COMM | 34962G208 |
| RACC | RESEARCH ALLIANCE CORP CL A | 500,000 | $5.35M | 0.1% | — | — | COMM | G75226103 |
| JATT | JATT II ACQUISITION CORP | 200,000 | $2.272M | 0.1% | — | — | COMM | G50765109 |
| EIKN | EIKON THERAPEUTICS INC | 37,902 | $495K | 0.0% | — | — | COMM | 282564103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVTX | AVALO THERAPEUTICS INC | 3,017,120 (+308.6%) | $55.76M (+405.8%) | 1.3% | — | — | COMM | 05338F306 |
| MNPR | MONOPAR THERAPEUTICS INC | 203,327 (+53.9%) | $18.83M (+160.1%) | 0.5% | — | — | COMM | 61023L207 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4,286,480 | $170M | 4.1% | — | — | — | 152309100 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $40.27M | 1.0% | — | — | — | 359616109 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 403,048 | $15.21M | 0.4% | — | — | — | 53635D202 |
| URGN | UROGEN PHARMA LTD | 405,365 | $7.288M | 0.2% | — | — | — | M96088105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 140,411 | $6.768M | 0.2% | — | — | — | 86366E106 |
| UPB | UPSTREAM BIO INC | 181,063 | $1.63M | 0.0% | — | — | — | 91678A107 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $1.53M | 0.0% | — | — | — | 92840H400 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,007,834 (-7.3%) | $801M (+10.9%) | 19.2% | — | — | COMM | 00370M103 |
| TNGX | TANGO THERAPEUTICS INC | 9,081,201 (-13.8%) | $284M (+28.9%) | 6.8% | — | — | COMM | 87583X109 |
| TRDA | ENTRADA THERAPEUTICS INC | 1,060,230 (-53.7%) | $7.803M (-73.0%) | 0.2% | — | — | COMM | 29384C108 |
| ARVN | ARVINAS HOLDING CO LLC | 707,098 (-70.4%) | $5.876M (-76.8%) | 0.1% | — | — | COMM | 04335A105 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 5,655,487 (-56.5%) | $11.71M (-55.1%) | 0.3% | — | — | COMM | 00166B105 |
| BHVN | BIOHAVEN LTD | 1,779,952 (-61.6%) | $26.49M (-32.4%) | 0.6% | — | — | COMM | G1110E107 |
| RVMD | REVOLUTION MEDICINES INC | 340,899 (-40.9%) | $63.84M (+13.9%) | 1.5% | — | — | COMM | 76155X100 |
| COGT | COGENT BIOSCIENCES INC | 4,854,436 (-1.9%) | $188M (-1.3%) | 4.5% | — | — | COMM | 19240Q201 |
| LBRX | LB PHARMACEUTICALS INC | 1,447,310 (-21.3%) | $46.97M (+3.7%) | 1.1% | — | — | COMM | 50180M108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 1,900,582 | $169M | 4.1% | — | — | COMM | 00773J202 |
| IMVT | IMMUNOVANT INC | 4,457,988 | $172M | 4.1% | — | — | COMM | 45258J102 |
| RLAY | RELAY THERAPEUTICS INC | 4,273,356 | $79.95M | 1.9% | — | — | COMM | 75943R102 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,622,151 | $112M | 2.7% | — | — | COMM | 61225M102 |
| ADCT | ADC THERAPEUTICS SA | 11,390,175 | $12.19M | 0.3% | — | — | COMM | H0036K147 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,062,049 | $124M | 3.0% | — | — | COMM | 604749101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 6,243,812 | $112M | 2.7% | — | — | COMM | 03237H101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,676,624 | $163M | 3.9% | — | — | COMM | 252828108 |
| TYRA | TYRA BIOSCIENCES INC | 3,248,980 | $104M | 2.5% | — | — | COMM | 90240B106 |
| DYN | DYNE THERAPEUTICS INC | 4,615,144 | $103M | 2.5% | — | — | COMM | 26818M108 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $33.31M | 0.8% | — | — | ADRS | 82686Q101 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $35.88M | 0.9% | — | — | COMM | 55287L101 |
| CGON | CG ONCOLOGY INC | 3,670,206 | $261M | 6.3% | — | — | COMM | 156944100 |
| IRON | DISC MEDICINE INC | 1,341,862 | $98.14M | 2.4% | — | — | COMM | 254604101 |
| XNCR | XENCOR INC | 2,452,138 | $39.48M | 0.9% | — | — | COMM | 98401F105 |
| SVRA | SAVARA INC | 12,362,205 | $76.15M | 1.8% | — | — | COMM | 805111101 |
| VOR | VOR BIOPHARMA INC | 5,673,078 | $104M | 2.5% | — | — | COMM | 929033207 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 7,915,567 | $26.99M | 0.6% | — | — | COMM | 46489V302 |
| CNTX | CONTEXT THERAPEUTICS INC | 2,682,696 | $1.486M | 0.0% | — | — | COMM | 21077P108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 11,020,968 | $110M | 2.6% | — | — | COMM | 09058V103 |
| AGMB | AGOMAB THERAPEUTICS NV | 2,053,233 | $26.65M | 0.6% | — | — | ADRS | 00860C102 |
| SRZN | SURROZEN INC | 1,473,101 | $38.23M | 0.9% | — | — | COMM | 86889P208 |
| IPSC | CENTURY THERAPEUTICS INC | 17,754,430 | $43.4M | 1.0% | — | — | COMM | 15673T100 |
| TECX | TECTONIC THERAPEUTIC INC | 1,204,891 | $41.42M | 1.0% | — | — | COMM | 878972108 |
| JANX | JANUX THERAPEUTICS INC | 1,789,617 | $27.49M | 0.7% | — | — | COMM | 47103J105 |
| OCUL | OCULAR THERAPEUTIX INC | 1,647,752 | $16.18M | 0.4% | — | — | COMM | 67576A100 |
| CGEM | CULLINAN THERAPEUTICS INC | 406,786 | $7.408M | 0.2% | — | — | COMM | 230031106 |
| ALEC | ALECTOR INC | 10,000,000 | $20.1M | 0.5% | — | — | COMM | 014442107 |
| KOD | KODIAK SCIENCES INC | 1,445,538 | $56.32M | 1.4% | — | — | COMM | 50015M109 |
| KRRO | KORRO BIO INC | 416,301 | $5.487M | 0.1% | — | — | COMM | 500946108 |
| LONA | LEONABIO INC | 464,398 | $4.268M | 0.1% | — | — | COMM | 04746L203 |